Peiwei Yang
-
- Cancer-related molecular mechanisms research 3
-
- CAR-T cell therapy research 5
-
- Immunotherapy and Immune Responses 4
- Immune Cell Function and Interaction 4
-
- RNA modifications and cancer 2
- RNA Research and Splicing 2
- Advanced biosensing and bioanalysis techniques 1
-
- Flavonoids in Medical Research 2
- Cited by
- Cancer ResearchOncologyImmunology
In The Last Decade
Peiwei Yang
14 papers receiving 490 citations
Peers
Comparison fields: 5 of 67
- Cancer Research 150
- Oncology 169
- Immunology 111
- Molecular Biology 272
- Applied Microbiology and Biotechnology 6
Countries citing papers authored by Peiwei Yang
This map shows the geographic impact of Peiwei Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peiwei Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peiwei Yang more than expected).
Fields of papers citing papers by Peiwei Yang
This network shows the impact of papers produced by Peiwei Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peiwei Yang. The network helps show where Peiwei Yang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peiwei Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2023 | 10 | |
| 3 | 2022 | 23 | |
| 4 | 2022 | 18 | |
| 5 | 2021 | 28 | |
| 6 | 2021 | 67 | |
| 7 | 2021 | 38 | |
| 8 | 2020 | 23 | |
| 9 | 2020 | 57 | |
| 10 | 2020 | 42 | |
| 11 | 2019 | 56 | |
| 12 | 2018 | 83 | |
| 13 | 2018 | 43 | |
| 14 | 2017 | 1 |
About Peiwei Yang
Peiwei Yang is a scholar working on Immunology, Cancer Research, Oncology, Complementary and alternative medicine and Pharmacology, having authored 14 papers that have together received 493 indexed citations. Recurring topics across this work include CAR-T cell therapy research (5 papers), Immunotherapy and Immune Responses (4 papers), Immune Cell Function and Interaction (4 papers), Cancer-related molecular mechanisms research (3 papers), RNA modifications and cancer (2 papers), Flavonoids in Medical Research (2 papers), RNA Research and Splicing (2 papers) and Advanced biosensing and bioanalysis techniques (1 paper). The work is most often cited by research in Cancer Research (150 citations), Oncology (169 citations), Immunology (111 citations), Molecular Biology (272 citations) and Applied Microbiology and Biotechnology (6 citations). Peiwei Yang has collaborated with scholars based in China, Australia and France. Frequent co-authors include Mengwei Li, Hanmei Xu, Heming Wu, Shou‐Mei Wang, Yinan Zhang, Xiaojun Feng, Hanmei Xu, Erhao Zhang, Shu‐Hui Zhang and Xiangying Chen. Their work appears in journals such as Journal of the American Chemical Society, Cell Death and Disease, Frontiers in Oncology, Phytomedicine and Signal Transduction and Targeted Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.